[Hypolipemic effects of 1-10(hydroxy-2 ethylthio) decane (LL1558), based on 77 cases of essential hyperlipidemia].
D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D006018:Glycols / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000235:genetics*; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D013440:Sulfides / Q000009:adverse effects / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D006018:Glycols; D000960:Hypolipidemic Agents; D008055:Lipids; D013440:Sulfides; D014280:Triglycerides; D002784:Cholesterol
Effets hypolipidémiants du bis (hydroxy-2 éthylthio) 1-10 décane (LL1558) à partir de 77 observations d'hyperlipidémie essentielle.